Skeletal muscle dysfunction in chronic renal failure: effects of exercise (Q36417652)

14 August 2017

1 reference

title

Skeletal muscle dysfunction in chronic renal failure: effects of exercise (English)

1 reference

14 August 2017

Gregory R Adams

1

1 reference

PubMed ID

16527920

14 August 2017

Nosratola D Vaziri

series ordinal

2

1 reference

14 August 2017

1 April 2006

1 reference

American Journal of Physiology - Renal Physiology

14 August 2017

1 reference

14 August 2017

290

1 reference

14 August 2017

4

1 reference

14 August 2017

F753-61

1 reference

Skeletal muscle unweighting: spaceflight and ground-based models

14 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Voluntary exercise during chronic renal failure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

The fitness, obesity, and health equation: is physical activity the common denominator?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Regulation of protein synthesis associated with skeletal muscle hypertrophy by insulin-, amino acid- and exercise-induced signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Neurological complications in renal failure: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Carnitine replacement in end-stage renal disease and hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Insulin resistance and postprandial triglyceride levels in primary renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Morphologic features of the myopathy associated with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Markers of inflammation, proteolysis, and apoptosis in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

The prevalence of insulin resistance in kidney disease patients before the development of renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

An evolutionary perspective on human physical activity: implications for health

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

The molecular basis for oxidative stress-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Molecular signaling pathways regulating muscle proteolysis during atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Leisure time, occupational and household physical activity, and risk factors for cardiovascular disease in working men and women: the WOLF study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

IL-6-induced skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Resistance training improves strength and functional measures in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

The pituitary-testicular axis in men with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Protein and energy: recommended intake and nutrient supplementation in chronic dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Assessment of nutritional status in CAPD patients: serum albumin is not a useful measure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Exercise training in patients with end-stage renal disease on hemodialysis: comparison of three rehabilitation programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Combined ingestion of protein and free leucine with carbohydrate increases postexercise muscle protein synthesis in vivo in male subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Evidence for exercise therapy in the treatment of chronic disease based on at least three randomized controlled trials--summary of published systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

21 January 2018

Sedentary death syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Does hemodialysis increase protein breakdown? Dissociation between whole-body amino acid turnover and regional muscle kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Protein metabolism in patients with chronic renal failure: role of uremia and dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Insulin is protein-anabolic in chronic renal failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Intradialytic exercise as anabolic therapy in haemodialysis patients -- a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Effect of metabolic acidosis on branched-chain amino acids in uremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Chronic kidney disease: the global challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Amino acid signalling and the integration of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Skeletal muscle mitochondrial function is preserved in young patients with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Malnutrition: a frequent misdiagnosis for hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Actual Causes of Death in the United States, 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Altered muscle energy metabolism in post-absorptive patients with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Kidney function during exercise in healthy and diseased humans. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Exercise augments the acute anabolic effects of intradialytic parenteral nutrition in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Effects of strength, endurance and combined training on myosin heavy chain content and fibre-type distribution in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

New concepts: growth hormone, insulin-like growth factor-I and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Coordinated increase in albumin, fibrinogen, and muscle protein synthesis during hemodialysis: role of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Changes in muscle morphology in dialysis patients after 6 months of aerobic exercise training

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Clinical and demographic predictors of exercise capacity in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

The association between congestive heart failure and chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Regulation of gonadal function in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Metabolic acidosis and malnutrition in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Physical activity and risk of colorectal cancer in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Activation of opioid mu-receptors by loperamide to improve interleukin-6-induced inhibition of insulin signals in myoblast C2C12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

Down-regulation of VLDL receptor expression in chronic experimental renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00296.2005

10.1152/AJPRENAL.00296.2005

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16527920